WallStreetZenWallStreetZen

NASDAQ: PRME
Prime Medicine Inc Stock

$7.00+0.24 (+3.55%)
Updated Mar 28, 2024
PRME Price
$7.00
Fair Value Price
$0.31
Market Cap
$839.57M
52 Week Low
$5.54
52 Week High
$17.20
P/E
-3.21x
P/B
6.31x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$198.13M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.46
Operating Cash Flow
-$165M
Beta
1.62
Next Earnings
May 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

PRME Overview

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PRME scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PRME ($7.00) is overvalued by 2,179.04% relative to our estimate of its Fair Value price of $0.31 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
PRME ($7.00) is not significantly undervalued (2,179.04%) relative to our estimate of its Fair Value price of $0.31 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PRME is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PRME due diligence checks available for Premium users.

Be the first to know about important PRME news, forecast changes, insider trades & much more!

PRME News

Valuation

PRME fair value

Fair Value of PRME stock based on Discounted Cash Flow (DCF)
Price
$7.00
Fair Value
$0.31
Overvalued by
2,179.04%
PRME ($7.00) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PRME ($7.00) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PRME is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PRME price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.21x
Industry
14.26x
Market
44.51x

PRME price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.31x
Industry
6.21x
PRME is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PRME's financial health

Profit margin

Revenue
$0.0
Net Income
-$65.6M
Profit Margin
0%
PRME's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$193.9M
Liabilities
$60.8M
Debt to equity
0.46
PRME's short-term assets ($142.98M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRME's short-term assets ($142.98M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRME's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$43.9M
Investing
$41.3M
Financing
$194.0k
PRME's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PRME vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
PRME$839.57M+3.55%-3.21x6.31x
TNGX$847.34M+3.12%-7.35x3.35x
HLVX$826.52M+6.47%-5.47x3.11x
SLN$854.84M-1.01%N/A39.61x
AVTE$823.91M+3.75%-10.30x7.53x

Prime Medicine Stock FAQ

What is Prime Medicine's quote symbol?

(NASDAQ: PRME) Prime Medicine trades on the NASDAQ under the ticker symbol PRME. Prime Medicine stock quotes can also be displayed as NASDAQ: PRME.

If you're new to stock investing, here's how to buy Prime Medicine stock.

What is the 52 week high and low for Prime Medicine (NASDAQ: PRME)?

(NASDAQ: PRME) Prime Medicine's 52-week high was $17.20, and its 52-week low was $5.54. It is currently -59.3% from its 52-week high and 26.35% from its 52-week low.

How much is Prime Medicine stock worth today?

(NASDAQ: PRME) Prime Medicine currently has 119,939,247 outstanding shares. With Prime Medicine stock trading at $7.00 per share, the total value of Prime Medicine stock (market capitalization) is $839.57M.

Prime Medicine stock was originally listed at a price of $15.76 in Oct 21, 2022. If you had invested in Prime Medicine stock at $15.76, your return over the last 1 years would have been -55.58%, for an annualized return of -55.58% (not including any dividends or dividend reinvestments).

How much is Prime Medicine's stock price per share?

(NASDAQ: PRME) Prime Medicine stock price per share is $7.00 today (as of Mar 28, 2024).

What is Prime Medicine's Market Cap?

(NASDAQ: PRME) Prime Medicine's market cap is $839.57M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Prime Medicine's market cap is calculated by multiplying PRME's current stock price of $7.00 by PRME's total outstanding shares of 119,939,247.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.